TGA Approval

OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial (275778)

ARTG ID

275778

ARTG Name

OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial

Sponsor

Roche Products Pty Ltd

ARTG Date

July 13, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ROCHE PRODUCTS PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02092-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-02089-1

Ingredient Name

ocrelizumab

Empowering clinical research with data-driven insights and AI-powered tools.

OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial (275778) - TGA 批准文号 | MedPath